Linking inflammation and hypertension in humans: Studies in Bartter's/ Gitelman's syndrome patients

Journal of Human Hypertension

Volumn 22, Issue 3, 2008, Pages 223-225

  Calo L A ^a   Davis, P A ^b   Pagnin, E ^a   Schiavo, S ^a   Semplicini, A ^a   Pessina, A C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; I KAPPA B; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P66;

ARTICLE; ATHEROSCLEROSIS; BARTTER SYNDROME; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME PHOSPHORYLATION; GITELMAN SYNDROME; HUMAN; HUMAN CELL; HYPERTENSION; INFLAMMATION; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOTENSIN II; BARTTER SYNDROME; BLOTTING, WESTERN; CASE-CONTROL STUDIES; EIF-2 KINASE; FEMALE; GITELMAN SYNDROME; HUMANS; HYPERTENSION; INFLAMMATION; MALE; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 39449119733     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002309     Document Type: Article

References (12)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
2. Pauletto P, Rattazzi M. Inflammation and hypertension: The search for a link. Nephrol Dial Transplant 2006; 21: 850-853.
3. Das UN. Is angiotensin II an endogenous pro-inflammatory molecule? Med Sci Monit 2005; 11: 155-162.
4. Lassegue B, Griendling KK. Reactive oxygen species in hypertension. Am J Hypertens 2004; 17: 852-860.
5. Cal LA, Pessina AC, Semplicini A. Angiotensin II signaling in. the Bartter's and Gitelman's syndromes, a negative human model of hypertension. High Blood Press Cardiovasc Prev 2005; 12: 17-26.
6. Caló LA. Vascular tone control in humans: The utility of studies in Bartter's/Gitelman's syndromes. Kidney Int 2006; 69: 963-966.
7. Caló LA, Pessina AC. RhoA/Rho-kinase pathway: Much more than just a modulation of vascular tone. Evidence from studies in humans. J Hypertens 2007; 25: 259-264.
8. Davis PA, Mussap M, Pagnin E, Bertipaglia L, Savica V, Semplicini A et al. Early markers of inflammation in a high angiotensin II state. Results of studies in Bartter's/Gitelman's syndromes. Nephrol Dial Transplant 2006; 21: 1697-1701.
9. Mehta PK, Griendling KK. Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007; 292: C82-C97.
10. Semplicini A, Lepzini L, Sartori M, Papparella I, Calo LA, Pagnin E et al. Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/ 2 phosphorylation induced by angiotensin II. J Hypertens 2006; 24: 1115-1124.
11. Graiani G, Lagrasta C, Migliaccio E, Spillmann F, Meloni M, Madeddu P et al. Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage. Hypertension 2005; 46 433-440.
12. de Winther MP, Kanters E, Kraal G, Hofker MH. Nuclear factor kappa B signaling in atherogenesis. Arterioscler Thromb Vasc Biol 2005; 25: 904-914.